GelMA‐Based Hydrogel Encapsulating Astragalus Polysaccharides and Umbilical Cord Mesenchymal Stem Cell Exosomes Promotes Full‐Thickness Skin Wound Healing
Chronic Diseases and Translational Medicine · 2026
DOI: 10.1002/cdt3.70072 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chronic Diseases and Translational Medicine, 2026. Verfasst von Jingwen Tian und 7 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi Key Laboratory of Special Biomedicine, School of Medicine, Guangxi University Nanning Guangxi China. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Basic Research Program of China.
Themen: Wundversorgung
Abstract (Originalsprache)
Background
Wound healing involves excessive oxidative stress and cellular dysfunction, while current single therapies remain inadequate. Astragalus polysaccharides (APS) and exosomes (Exos) possess antioxidative and regenerative properties, and gelatin methacryloyl (GelMA) hydrogel provides a biocompatible platform for localized delivery. Here, we developed an APS–Exos@GelMA hydrogel to promote wound repair.
Methods
The biological effects of APS and Exos were assessed through in vitro cellular assays, while the physicochemical properties and biocompatibility of APS–Exos@GelMA were characterized. Its therapeutic efficacy was further evaluated in a full‐thickness skin defect model through macroscopic observation and histological analysis.
Results
APS–Exos treatment showed enhanced effects compared with APS or Exos alone, improving fibroblast (130.90% ± 2.98%, p < 0.05) and keratinocyte (124.50% ± 3.18%, p < 0.01) viability, promoting fibroblast migration (74.15% ± 7.72%), and reducing oxidative damage (72.11% ± 2.13%). APS–Exos@GelMA maintained favorable hydrogel properties and biocompatibility while enabling localized incorporation and application of APS and Exos. In vivo, APS–Exos@GelMA accelerated wound closure, promoted epidermal reconstruction and extracellular matrix deposition, and exhibited good biosafety.
Conclusion
The combination of APS and Exos within an appropriate concentration range demonstrated improved therapeutic potential compared with individual treatments. The APS–Exos@GelMA hydrogel served as a biocompatible localized delivery platform to facilitate tissue repair, highlighting its potential for wound‐healing applications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Guangxi Key Laboratory of Special Biomedicine, School of Medicine, Guangxi University Nanning Guangxi China.
- Department of Obstetrics Women and Children's Hospital Affiliated to Xiamen University Xiamen Fujian China.
- Plastic Surgery Department Xiang'an Hospital of Xiamen University Xiamen Fujian China.
ORCID-Profile: Jingwen Tian
Förderung
- National Basic Research Program of China
Zitieren
APA
Tian, J., Zhao, X., Xie, J., Huang, Z., Song, P., Hong, S., Tong, C., & Qi, Z. (2026). GelMA‐Based Hydrogel Encapsulating Astragalus Polysaccharides and Umbilical Cord Mesenchymal Stem Cell Exosomes Promotes Full‐Thickness Skin Wound Healing. Chronic Diseases and Translational Medicine. https://doi.org/10.1002/cdt3.70072
Vancouver
Tian J, Zhao X, Xie J, Huang Z, Song P, Hong S, et al. GelMA‐Based Hydrogel Encapsulating Astragalus Polysaccharides and Umbilical Cord Mesenchymal Stem Cell Exosomes Promotes Full‐Thickness Skin Wound Healing. Chronic Diseases and Translational Medicine. 2026. doi:10.1002/cdt3.70072
BibTeX
@article{Tian2026,
author = {Tian, Jingwen and Zhao, Xiangjing and Xie, Jingxian and Huang, Zheng and Song, Pengbo and Hong, Suzhuang and Tong, Cailing and Qi, Zhongquan},
title = {GelMA‐Based Hydrogel Encapsulating Astragalus Polysaccharides and Umbilical Cord Mesenchymal Stem Cell Exosomes Promotes Full‐Thickness Skin Wound Healing},
journal = {Chronic Diseases and Translational Medicine},
year = {2026},
doi = {10.1002/cdt3.70072}
}
EUVIMED